Ledger.Open graph →
SEC Form D · filed March 12, 2024

ONL Therapeutics, Inc

Offering
$10.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Ann Arbor, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Stella Robertson · Ann Arbor, MIDirectorConstance Chang · Ann Arbor, MIExecMark Hooper · Ann Arbor, MIDirectorDavid Zacks · Ann Arbor, MIExec · DirectorDavid Esposito · Ann Arbor, MIExec · DirectorBill Burns · Ann Arbor, MIDirectorMichael Turner · Winchester, VADirectorSean E. Foster · San Juan, Puerto RicoExec · DirectorMiguel E. Prendens · Winchester, VADirectorSeth E. Roderick · Harrisonburg, VAExecGreg E. White · Fernandina Beach, FLExec · DirectorSampson L. Glassman · Winchester, VADirectorAri A. Santiago · Clayton, MODirectorHarold A. Thomas, Jr · Clayton, MOExecJames L. Alt · New York, NYExec · DirectorMichael L. Appel · New York, NYDirectorDavid Tingley · Naples, FLExec · DirectorPalisade Partners, Inc · Englewood, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗